Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Debt Ratio (2016 - 2022)

Aptevo Therapeutics (APVO) has disclosed Debt Ratio for 8 consecutive years, with 0.1 as the latest value for Q4 2022.

  • Quarterly Debt Ratio fell 62.81% to 0.1 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was 0.1 through Dec 2022, down 62.81% year-over-year, with the annual reading at 0.1 for FY2022, 62.81% down from the prior year.
  • Debt Ratio hit 0.1 in Q4 2022 for Aptevo Therapeutics, down from 0.12 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.67 in Q3 2020 to a low of 0.1 in Q4 2022.
  • Historically, Debt Ratio has averaged 0.26 across 5 years, with a median of 0.24 in 2019.
  • Biggest five-year swings in Debt Ratio: surged 106.93% in 2020 and later plummeted 64.78% in 2021.
  • Year by year, Debt Ratio stood at 0.29 in 2018, then surged by 30.21% to 0.37 in 2019, then increased by 25.81% to 0.47 in 2020, then plummeted by 41.95% to 0.27 in 2021, then tumbled by 62.81% to 0.1 in 2022.
  • Business Quant data shows Debt Ratio for APVO at 0.1 in Q4 2022, 0.12 in Q3 2022, and 0.11 in Q2 2022.